	Three Months Ended
	March 31			June 30		September 30			December 31
2014
Net sales	$	1,246.1		$	1,314.2	$	1,358.7		$	1,426.5
Gross profit	388.9			416.8		431.7			456.7
Operating income	232.1		(1)	255.8		267.8		(2)	278.9		(3)
Net income attributable to Amphenol Corporation	158.5		(1)	174.9		182.2		(2)	193.5		(3)

Net income per common share—Basic	0.50		(1)	0.56		0.58		(2)	0.62		(3)
Net income per common share—Diluted	0.49		(1)	0.54		0.57		(2)	0.61		(3)

2013
Net sales	$	1,079.8		$	1,136.1	$	1,153.1		$	1,245.7
Gross profit	337.9			359.8		363.8			389.3
Operating income	207.0			224.0		224.5		(5)	241.4		(6)
Net income attributable to Amphenol Corporation	153.0		(4)	154.0		160.8		(5)	167.9		(6)

Net income per common share—Basic	0.48		(4)	0.48		0.51		(5)	0.53		(6)
Net income per common share—Diluted	0.47		(4)	0.47		0.50		(5)	0.52		(6)

(1)

Operating income, net income and net income per common share includes acquisition-related expenses of $2.0 ($1.3 after-tax), or $0.01 per share, relating to the amortization of the value associated with acquired backlog relating to an acquisition completed by the Company in the fourth quarter of 2013. Excluding this effect, net income per common share-diluted was $0.50 for the three months ended March 31, 2014.

(2)

Operating income, net income and net income per common share includes acquisition-related expenses of $2.5 ($2.5 after-tax), or $0.01 per share relating to 2014 acquisitions. Excluding this effect, net income per common share-diluted was $0.58 for the three months ended September 30, 2014.

(3)

Operating income, net income and net income per common share includes acquisition-related expenses of $1.8 ($1.5 after-tax) relating to 2014 acquisitions and $7.8 ($4.9 after-tax) relating to the acquired backlog of an acquisition completed in the third quarter of 2014 which aggregates $0.02 per share. Excluding these effects, net income per common share-diluted was $0.63 for the three months ended December 31, 2014.

(4)

Net income and net income per common share includes an income tax benefit of $11.3, or $0.03 per share, resulting from the delay, by the U. S. government, in the reinstatement of certain federal income tax provisions for the year 2012 relating primarily to research and development credits and certain U.S. taxes on foreign income. Such tax provisions were reinstated on January 2, 2013 with retroactive effect to 2012. Under U.S. GAAP, the benefit to the Company of $11.3 relating to the 2012 tax year was recorded as a benefit in the first quarter of 2013 at the date of reinstatement. Excluding this effect, net income per common share-diluted was $0.44 for the three months ended March 31, 2013.

(5)

Operating income, net income and net income per common share includes acquisition-related transaction expenses of $2.5 ($2.1 after tax) or $0.01 per share, relating to 2013 acquisitions. Net income and net income per common share also includes a $3.6, or $0.02 per share, income tax benefit due primarily to the favorable completion of prior year audits. Excluding the effect of these items, net income per common share-diluted was $0.49 for the three months ended September 30, 2013.

(6)

Operating income, net income and net income per common share includes acquisition-related expenses of $3.4, ($2.4 after tax) or $0.01 per share, relating to 2013 acquisitions. Excluding this effect, net income per common share-diluted was $0.53 for the three months ended December 31, 2013.